Synta Pharmaceuticals Corp. (MDGL)

Last Three Months

25-Aug-24 -- 24-Nov-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Diagnostic Substances

Drugs

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

2

(1)

36

0

0

+1

0

+2

0

+3

Two Year Chart

25-Nov-22 -- 24-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
17-Sep-24 8:36 PM View:	13-Sep-24 Gift 0	Craves Fred B Director		Synta Pharmaceuticals Corp. - MDGL	(4%) 405.55K to 390.55K	0	0	--	--	Show Txns Hide Txns

11-Sep-24 9:51 PM View:	09-Sep-24 Private Sale ($1.55M)	Sibold William John President and CEO Director		Synta Pharmaceuticals Corp. - MDGL	(10%) 62.25K to 55.89K	0	0	--	--	Show Txns Hide Txns

22-Nov-24 4:30 PM View:	21-Nov-24 Private Sale ($218.04K)	Huntsman Carole Chief Commercial Officer		Synta Pharmaceuticals Corp. - MDGL	(6%) 11.47K to 10.79K	0	0	--	--	Show Txns Hide Txns